Original article
Lipoprotein apheresis efficacy and challenges: single center experience
Lido
5650
Vezesque se leu este artigo
1572
Total PDF
4078
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 11 | 142 | 9 | 151 |
| 2025 10 | 272 | 36 | 308 |
| 2025 9 | 264 | 24 | 288 |
| 2025 8 | 194 | 38 | 232 |
| 2025 7 | 163 | 38 | 201 |
| 2025 6 | 85 | 22 | 107 |
| 2025 5 | 97 | 22 | 119 |
| 2025 4 | 100 | 19 | 119 |
| 2025 3 | 70 | 21 | 91 |
| 2025 2 | 71 | 30 | 101 |
| 2025 1 | 80 | 25 | 105 |
| 2024 12 | 52 | 23 | 75 |
| 2024 11 | 68 | 28 | 96 |
| 2024 10 | 66 | 23 | 89 |
| 2024 9 | 65 | 26 | 91 |
| 2024 8 | 79 | 32 | 111 |
| 2024 7 | 62 | 47 | 109 |
| 2024 6 | 68 | 48 | 116 |
| 2024 5 | 42 | 37 | 79 |
| 2024 4 | 47 | 17 | 64 |
| 2024 3 | 56 | 17 | 73 |
| 2024 2 | 59 | 22 | 81 |
| 2024 1 | 44 | 24 | 68 |
| 2023 12 | 48 | 28 | 76 |
| 2023 11 | 66 | 31 | 97 |
| 2023 10 | 71 | 40 | 111 |
| 2023 9 | 112 | 50 | 162 |
| 2023 8 | 37 | 9 | 46 |
| 2023 7 | 46 | 23 | 69 |
| 2023 6 | 60 | 23 | 83 |
| 2023 5 | 45 | 24 | 69 |
| 2023 4 | 68 | 13 | 81 |
| 2023 3 | 73 | 24 | 97 |
| 2023 2 | 50 | 21 | 71 |
| 2023 1 | 53 | 10 | 63 |
| 2022 12 | 49 | 16 | 65 |
| 2022 11 | 46 | 29 | 75 |
| 2022 10 | 45 | 30 | 75 |
| 2022 9 | 50 | 22 | 72 |
| 2022 8 | 41 | 25 | 66 |
| 2022 7 | 46 | 33 | 79 |
| 2022 6 | 55 | 29 | 84 |
| 2022 5 | 64 | 21 | 85 |
| 2022 4 | 135 | 30 | 165 |
| 2022 3 | 89 | 46 | 135 |
| 2022 2 | 62 | 33 | 95 |
| 2021 1 | 55 | 30 | 85 |
| 2021 12 | 29 | 29 | 58 |
| 2021 11 | 28 | 25 | 53 |
| 2021 10 | 46 | 34 | 80 |
| 2021 9 | 35 | 24 | 59 |
| 2021 8 | 37 | 29 | 66 |
| 2021 7 | 29 | 25 | 54 |
| 2021 6 | 27 | 27 | 54 |
| 2021 5 | 34 | 33 | 67 |
| 2021 4 | 65 | 53 | 118 |
| 2021 3 | 36 | 25 | 61 |
Mostrar tudo
